Temozolomide Capsule Franchise in Ahmedabad

Brain Tumor Capsule Supplier in Mumbai

Oncology Capsule Distributor in Delhi

Cancer Care PCD Pharma Franchise in Bangalore

Temozolomide Capsule Stockist in Hyderabad
Antineoplastic Capsule Manufacturer & Exporter in Chandigarh

Home/Products /temozolomide-20mg-capsule

Temofan 20 Capsule

Composition : Temozolomide (20mg) Capsule

Dosage Form : Capsule

Packaging Type : in a Bottle

Packaging : 30 Capsules

Price : ₹0/-

Please Contact For Best Price

Temofan 20 Capsule contains Temozolomide 20mg, an oral alkylating agent widely used in the treatment of primary brain tumors such as glioblastoma multiforme and astrocytoma. It helps in slowing tumor growth and improving survival outcomes in patients with aggressive brain cancers.

Temozolomide works by alkylating/methylating DNA in cancer cells, which disrupts DNA replication and triggers cancer cell death. This mechanism allows it to target rapidly dividing tumor cells selectively while sparing most normal cells.

This capsule is commonly prescribed as part of adjuvant therapy or combination therapy with radiotherapy for brain tumors. Its oral formulation provides convenience for patients requiring long-term cancer management, enhancing adherence to treatment protocols.

For PCD pharma franchise partners, Temofan 20 Capsule is a high-demand oncology product, available at the best price for PCD pharma franchise. Its strong clinical demand, prescriber trust, and essential role in brain tumor management make it a valuable addition to any cancer care or oncology product portfolio.

Read More

About the Product

Temofan 20 Capsule contains Temozolomide 20mg, an oral alkylating agent widely used in the treatment of primary brain tumors such as glioblastoma multiforme and astrocytoma. It helps in slowing tumor growth and improving survival outcomes in patients with aggressive brain cancers.

Temozolomide works by alkylating/methylating DNA in cancer cells, which disrupts DNA replication and triggers cancer cell death. This mechanism allows it to target rapidly dividing tumor cells selectively while sparing most normal cells.

This capsule is commonly prescribed as part of adjuvant therapy or combination therapy with radiotherapy for brain tumors. Its oral formulation provides convenience for patients requiring long-term cancer management, enhancing adherence to treatment protocols.

For PCD pharma franchise partners, Temofan 20 Capsule is a high-demand oncology product, available at the best price for PCD pharma franchise. Its strong clinical demand, prescriber trust, and essential role in brain tumor management make it a valuable addition to any cancer care or oncology product portfolio.

Common side effects may include nausea, vomiting, fatigue, loss of appetite, and mild headache. Rare but serious side effects include bone marrow suppression, infections due to low blood counts, liver toxicity, or severe allergic reactions. Patients should seek immediate medical attention if severe symptoms occur.

Temofan 20 Capsule is indicated for the treatment of adult patients with newly diagnosed glioblastoma in combination with radiotherapy, as well as for recurrent anaplastic astrocytoma, as prescribed by a healthcare professional.

Temofan 20 Capsule should be taken exactly as prescribed, typically on an empty stomach. Regular monitoring of blood counts, liver function, and overall health is essential during therapy. Patients should inform their doctor of any history of infections, liver disease, or concurrent medications.

Store Temofan 20 Capsule in a cool, dry place away from direct sunlight and moisture. Keep out of reach of children and do not use after the expiry date indicated on the packaging.

Get in Touch